Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Piper Sandler MedTech and Diagnostics California Bus Tour on Wednesday, August 24,...

Envista Holdings Corporation (NYSE: NVST) today announced results for the second quarter 2022. As previously disclosed, on December 31, 2021, we completed the sale of the KaVo Treatment Unit and...

Envista Holdings Corporation ("Envista") announced today an extension and expansion of their commercial partnership with dentalcorp Holdings Ltd., Canada's largest DSO, network of dental...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2022 on Wednesday, August 3, 2022. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Stifel 2022 Jaws & Paws Conference on Wednesday, June 1, 2022, from 9:45 – 10:15 AM EST...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in William Blair Emerging Technologies in Dental Care Virtual Conference on Tuesday, May...

Envista Holdings Corporation (NYSE: NVST) today announced results for the first quarter 2022. As previously disclosed, on December 31, 2021, we completed the sale of the KaVo Treatment Unit and...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced the completion of the acquisition of Carestream Dental's Intraoral Scanner business. As previously announced, this business...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2022 on Wednesday, May 4, 2022. Envista will discuss these results on a conference call on...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced Envista's KaVo imaging business will be re-branded as "DEXIS". Dental professionals have known the DEXIS brand as the leader...

Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista announced today the 510(k) Food and Drug Administration (FDA) clearance of its Assisted Intelligence (AI) mandibular nerve tracing...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Piper Sandler Dental Day on Tuesday, March 29th from 7:00 – 7:45 AM PT. Investors will...

Envista Holdings Corporation (NYSE: NVST) today announced that the company will be holding an Investor Day at its Envista Summit on Friday, April 1st from 8:00 am – 10:30 am CT. Interested...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in Jefferies Virtual Dental Summit on Thursday, February 24th from 6:00 – 6:45 AM PST....

In the news release, Envista Reports Fourth Quarter 2021 Earnings, issued 09-Feb-2022 by Envista Holdings Corporation over PR Newswire, we are advised by the company that the third paragraph in...

Envista Holdings Corporation (NYSE: NVST) announced that it has renewed its partnership agreement with the Vitaldent Group, a leading Spanish Dental Service Organization (DSO). Vitaldent is...

Envista Holdings Corporation (NYSE: NVST) ("Envista") -- and leading dental support organization Pacific Dental Services® (PDS) announced today the extension of their implant and imaging...

Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2021 on Wednesday, February 9, 2022. Envista will discuss these results on a conference...

Envista Holdings Corporation (NYSE: NVST) ("Envista") -- Envista and leading dental support organization Pacific Dental Services® (PDS) announce today the consummation of a multi-year year...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that it closed the previously disclosed divestiture of its KaVo Treatment Unit & Instrument business. Envista received $317.3...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the U.S. Food and Drug Administration (FDA) has cleared the Nobel Biocare N1™ implant system. Boasting a biologically...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced an update to the company's participation at the 40th Annual J.P. Morgan Healthcare Conference. Envista will present virtually...

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced it has entered into a definitive agreement to acquire Carestream Dental's Intra-Oral Scanner (IOS) business for $600 million....

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the following upcoming investor conferences: Stifel MedTech Madness 2021 Annual West...